Zhang Liqin, Zheng Guangping, Zhao Weicheng, He Chun, Huang Zhongming
The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou, China.
Ganzhou Municipal Key Laboratory of Bone and Joint Research, The Affiliated Ganzhou Hospital of Nanchang University, Meiguan Avenue No. 16, Ganzhou, 341000, China.
In Vitro Cell Dev Biol Anim. 2025 Mar;61(3):268-274. doi: 10.1007/s11626-024-01006-x. Epub 2024 Dec 24.
Maxing Yigan formula (MYF) is a traditional Chinese medicine (TCM) prescription used for the treatment of OA for decades in China. However, the mechanism remains unknown. In this study, we developed a MYF-incorporated collagen sponge (MYF@CS) and investigated its cartilage regeneration effect and the underlying mechanism. In vitro experiments revealed that MYF significantly promoted cell viability, proliferation, and autophagy of OA chondrocytes. Furthermore, MYF@CS significantly enhanced chondrogenesis and cartilage regeneration, as assessed by macroscopic observation, the International Cartilage Repair Society (ICRS) visual histological score, and histological examination. Our findings suggest that MYF@CS could represent a significant therapeutic strategy for the treatment of OA.
麻杏苡甘方(MYF)是一种中药方剂,在中国用于治疗骨关节炎已有数十年。然而,其作用机制尚不清楚。在本研究中,我们制备了一种负载麻杏苡甘方的胶原海绵(MYF@CS),并研究了其软骨再生效果及潜在机制。体外实验表明,MYF显著促进骨关节炎软骨细胞的细胞活力、增殖和自噬。此外,通过宏观观察、国际软骨修复协会(ICRS)视觉组织学评分和组织学检查评估,MYF@CS显著增强软骨形成和软骨再生。我们的研究结果表明,MYF@CS可能是一种治疗骨关节炎的重要治疗策略。